AXSOME THERAPEUTICS, INC. (AXSM) Capital expenditures 2016–2025
AXSOME THERAPEUTICS, INC. (AXSM) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$480,000FY2025 · since FY2016: $104,561 → $480,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $480,000 | +77.8% |
| FY2024 | $270,000 | -53.6% |
| FY2023 | $582,000 | -17.1% |
| FY2022 | $702,000 | +127.9% |
| FY2021 | $308,000 | +571.2% |
| FY2020 | $45,891 | +184.7% |
| FY2019 | $16,121 | -50.7% |
| FY2018 | $32,696 | +230.3% |
| FY2017 | $9,898 | -90.5% |
| FY2016 | $104,561 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice